20 LATEST RESOURCES (147 INDEXED)
Lithium Response in Bipolar Disorder: Epigenome-Wide DNA Methylation Signatures and Epigenetic Aging · April 2024
Articles
European Neuropsychopharmacology
Implementing Cognitive Screenings for Outpatients with Bipolar Disorder Following Optimised Treatment in a Specialised Mood Disorder Clinic · April 2024
Articles
European Neuropsychopharmacology
Single-Arm Meta-Analysis of Drug Response in Placebo-Controlled versus Active-Controlled Antipsychotic Drug Trials in Schizophrenia · April 2024
Articles
European Neuropsychopharmacology
Exploring the Association between Suicidal Thoughts, Self-Injury, and GLP-1 Receptor Agonists in Weight Loss Treatments: Insights from Pharmacovigilance Measures and Unmasking Analysis · March 2024
Articles
European Neuropsychopharmacology
Efficacy, Acceptability and Side-Effects of Oral versus Long-Acting- Injectables Antipsychotics: Systematic Review and Network Meta-Analysis · March 2024
Articles
European Neuropsychopharmacology
A Randomised, Placebo-Controlled, Double Blind, Crossover Trial on the Effect of a 20:1 Cannabidiol: A9-Tetrahydrocannabinol Medical Cannabis Product on Neurocognition, Attention, and Mood · March 2024
Articles
European Neuropsychopharmacology
Suicide Mortality in Spain during the COVID-19 Pandemic: Longitudinal Analysis of Sociodemographic Factors · March 2024
Articles
European Neuropsychopharmacology
Settling a Distracted Globe: An Overview of Psychosocial and Psychotherapeutic Treatment of Attention-Deficit/Hyperactivity Disorder · March 2024
Articles
European Neuropsychopharmacology
Does Valerian Work for Insomnia? An Umbrella Review of the Evidence · February 2024
Articles
European Neuropsychopharmacology
Current Level of Evidence for Improvement of Antidepressant Efficacy and Tolerability by Pharmacogenomic-Guided Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials · February 2024
Articles
European Neuropsychopharmacology
Rare Variants in Pharmacogenes Influence Clozapine Metabolism in Individuals with Schizophrenia · February 2024
Articles
European Neuropsychopharmacology
Whole-Brain Structural and Functional Neuroimaging of Individuals Who Attempted Suicide and People Who Did Not: A Systematic Review and Exploratory Coordinate-Based Meta-Analysis · January 2024
Articles
European Neuropsychopharmacology
Clinical Features in Co-Occuring Obsessive-Compulsive Disorder and Bipolar Disorder: A Systematic Review and Meta-Analysis · December 2023
Articles
European Neuropsychopharmacology
Duration of the Psychosis Prodrome and Its Relationship to Duration of Untreated Psychosis Across All 12 DSM-IV Psychotic Diagnoses: Evidence for a Trans-Diagnostic Process Associated with Resilience · December 2023
Articles
European Neuropsychopharmacology
EEG Abnormalities Are Not Associated with Poor Antidepressant Treatment Outcome – A Neuropharm Study · December 2023
Articles
European Neuropsychopharmacology
Effect of Erythropoietin on Cognitive Side-Effects of Electroconvulsive Therapy in Depression: A Randomized, Double-Blind, Placebo-Controlled Trial · December 2023
Articles
European Neuropsychopharmacology
From Gut to Brain: A Network Model of Intestinal Permeability, Inflammation, and Psychotic Symptoms in Schizophrenia · December 2023
Articles
European Neuropsychopharmacology
Cognitive Impairment After Recovery from COVID-19: Frequency, Profile, and Relationships with Clinical and Laboratory Indices · December 2023
Articles
European Neuropsychopharmacology
A Posterior-Alpha Ageing Network Is Differentially Associated with Antidepressant Effects of Venlafaxine and rTMS · November 2023
Articles
European Neuropsychopharmacology
Young People at Risk for Developing Bipolar Disorder: Two-Year Findings from the Multicenter Prospective, Naturalistic Early-BipoLife Study · October 2023
Articles
European Neuropsychopharmacology